Victrix Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Buy
26,958
+2,244
+9% +$263K 1.45% 25
2026
Q1
$2.97M Buy
24,714
+373
+2% +$43.1K 1.08% 35
2025
Q4
$2.56M Sell
24,341
-277
-1% -$26K 0.99% 35
2025
Q3
$2.07M Buy
24,618
+2,512
+11% +$207K 1.13% 28
2025
Q2
$1.75M Buy
22,106
+475
+2% +$37.8K 0.77% 41
2025
Q1
$1.84M Sell
21,631
-17
-0.1% -$1.59K 0.97% 37
2024
Q4
$2.15M Buy
+21,648
New +$2.23M 1.55% 24

Other funds holding MRK

Victrix Investment Advisors's MRK Position: Q2 2026 in Review

Victrix Investment Advisors increased its Merck (MRK) stake by 9.1% in Q2 2026, buying an estimated $263K and bringing the position to 26,958 shares worth $3.46M. The position accounts for 1.45% of the portfolio, ranked #25.

Victrix Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Victrix Investment Advisors held 26,958 shares of Merck worth $3.46M as of Q2 2026.
  • Victrix Investment Advisors bought 2,244 Merck shares in Q2 2026, an estimated $263K.
  • Merck made up 1.45% of Victrix Investment Advisors's portfolio in Q2 2026, its #25 holding.
  • Victrix Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.